| Estimates of the burden of group B streptococcal disease worldwide for pregnant women, stillbirths, and children AC Seale, F Bianchi-Jassir, NJ Russell, M Kohli-Lynch, CJ Tann, J Hall, ... Clinical infectious diseases 65 (suppl_2), S200-S219, 2017 | 459 | 2017 |
| Maternal Colonization With Group B Streptococcus and Serotype Distribution Worldwide: Systematic Review and Meta-analyses NJ Russell, AC Seale, M O’Driscoll, C O’Sullivan, F Bianchi-Jassir, ... Clinical infectious diseases 65 (suppl_2), S100-S111, 2017 | 455 | 2017 |
| Infant group B streptococcal disease incidence and serotypes worldwide: systematic review and meta-analyses L Madrid, AC Seale, M Kohli-Lynch, KM Edmond, JE Lawn, PT Heath, ... Clinical infectious diseases 65 (suppl_2), S160-S172, 2017 | 394 | 2017 |
| Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial VG Fowler, KB Allen, ED Moreira, M Moustafa, F Isgro, HW Boucher, ... Jama 309 (13), 1368-1378, 2013 | 388 | 2013 |
| Preterm birth associated with group B Streptococcus maternal colonization worldwide: systematic review and meta-analyses F Bianchi-Jassir, AC Seale, M Kohli-Lynch, JE Lawn, CJ Baker, L Bartlett, ... Clinical Infectious Diseases 65 (suppl_2), S133-S142, 2017 | 214 | 2017 |
| Intrapartum antibiotic chemoprophylaxis policies for the prevention of group B streptococcal disease worldwide: systematic review K Le Doare, M O’Driscoll, K Turner, F Seedat, NJ Russell, AC Seale, ... Clinical infectious diseases 65 (suppl_2), S143-S151, 2017 | 201 | 2017 |
| Neurodevelopmental impairment in children after group B streptococcal disease worldwide: systematic review and meta-analyses M Kohli-Lynch, NJ Russell, AC Seale, Z Dangor, CJ Tann, CJ Baker, ... Clinical Infectious Diseases 65 (suppl_2), S190-S199, 2017 | 199 | 2017 |
| Risk of early-onset neonatal group B streptococcal disease with maternal colonization worldwide: systematic review and meta-analyses NJ Russell, AC Seale, C O’Sullivan, K Le Doare, PT Heath, JE Lawn, ... Clinical infectious diseases 65 (suppl_2), S152-S159, 2017 | 192 | 2017 |
| Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trial SA Madhi, CL Cutland, L Jose, A Koen, N Govender, F Wittke, M Olugbosi, ... The Lancet infectious diseases 16 (8), 923-934, 2016 | 160 | 2016 |
| Strengthening the Reporting of Observational Studies in Epidemiology for Newborn Infection (STROBE-NI): an extension of the STROBE statement for neonatal infection research EJA Fitchett, AC Seale, S Vergnano, M Sharland, PT Heath, SK Saha, ... The Lancet infectious diseases 16 (10), e202-e213, 2016 | 154 | 2016 |
| Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early … SA Madhi, Z Dangor, PT Heath, S Schrag, A Izu, A Sobanjo-ter Meulen, ... Vaccine 31, D52-D57, 2013 | 139 | 2013 |
| Maternal disease with group B Streptococcus and serotype distribution worldwide: systematic review and meta-analyses J Hall, NH Adams, L Bartlett, AC Seale, T Lamagni, F Bianchi-Jassir, ... Clinical infectious diseases 65 (suppl_2), S112-S124, 2017 | 136 | 2017 |
| Stillbirth With Group B Streptococcus Disease Worldwide: Systematic Review and Meta-analyses AC Seale, H Blencowe, F Bianchi-Jassir, N Embleton, Q Bassat, J Ordi, ... Clinical infectious diseases 65 (suppl_2), S125-S132, 2017 | 135 | 2017 |
| Group B streptococcal disease worldwide for pregnant women, stillbirths, and children: why, what, and how to undertake estimates? JE Lawn, F Bianchi-Jassir, NJ Russell, M Kohli-Lynch, CJ Tann, J Hall, ... Clinical infectious diseases 65 (suppl_2), S89-S99, 2017 | 120 | 2017 |
| WHO consultation on group B Streptococcus vaccine development: report from a meeting held on 27–28 April 2016 M Kobayashi, SJ Schrag, MR Alderson, SA Madhi, CJ Baker, ... Vaccine 37 (50), 7307-7314, 2019 | 114 | 2019 |
| Group B streptococcus infection during pregnancy and infancy: estimates of regional and global burden BP Gonçalves, SR Procter, P Paul, J Chandna, A Lewin, F Seedat, ... The Lancet Global Health 10 (6), e807-e819, 2022 | 83 | 2022 |
| Safety, tolerability, and immunogenicity of 15-valent pneumococcal conjugate vaccine in healthy adults R McFetridge, A Sobanjo-ter Meulen, SD Folkerth, JA Hoekstra, M Dallas, ... Vaccine 33 (24), 2793-2799, 2015 | 70 | 2015 |
| Neonatal encephalopathy with group B streptococcal disease worldwide: systematic review, investigator group datasets, and meta-analysis CJ Tann, KA Martinello, S Sadoo, JE Lawn, AC Seale, M Vega-Poblete, ... Clinical Infectious Diseases 65 (suppl_2), S173-S189, 2017 | 68 | 2017 |
| Antibody Kinetics and Response to Routine Vaccinations in Infants Born to Women Who Received an Investigational Trivalent Group B Streptococcus Polysaccharide CRM … SA Madhi, A Koen, CL Cutland, L Jose, N Govender, F Wittke, M Olugbosi, ... Clinical Infectious Diseases 65 (11), 1897-1904, 2017 | 62 | 2017 |
| Safety, tolerability and immunogenicity of 15-valent pneumococcal conjugate vaccine in toddlers previously vaccinated with 7-valent pneumococcal conjugate vaccine A Sobanjo-ter Meulen, T Vesikari, EA Malacaman, SA Shapiro, MJ Dallas, ... The Pediatric infectious disease journal 34 (2), 186-194, 2015 | 62 | 2015 |
